Bionano Genomics (NASDAQ:BNGO) Stock Price Down 7.5% – Here’s What Happened

Shares of Bionano Genomics, Inc. (NASDAQ:BNGO) fell 7.5% on Monday . The company traded as low as $4.84 and last traded at $4.96. 138,101 shares traded hands during trading, a decline of 52% from the average session volume of 288,391 shares. The stock had previously closed at $5.36.

Analyst Ratings Changes

Separately, LADENBURG THALM/SH SH downgraded Bionano Genomics from a “buy” rating to a “neutral” rating in a research report on Friday, November 15th.

Bionano Genomics Stock Performance

The business has a 50 day simple moving average of $9.91 and a 200 day simple moving average of $17.55. The company has a quick ratio of 0.99, a current ratio of 1.43 and a debt-to-equity ratio of 0.07. The company has a market capitalization of $9.69 million, a PE ratio of -0.04 and a beta of 2.14.

Institutional Investors Weigh In On Bionano Genomics

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Carret Asset Management LLC raised its stake in Bionano Genomics by 89.0% in the third quarter. Carret Asset Management LLC now owns 85,055 shares of the company’s stock valued at $39,000 after buying an additional 40,055 shares during the last quarter. GSA Capital Partners LLP purchased a new stake in Bionano Genomics in the third quarter valued at about $46,000. XTX Topco Ltd purchased a new stake in Bionano Genomics in the fourth quarter valued at about $45,000. Renaissance Technologies LLC purchased a new stake in Bionano Genomics in the fourth quarter valued at about $46,000. Finally, Jane Street Group LLC purchased a new stake in Bionano Genomics in the fourth quarter valued at about $118,000. 11.35% of the stock is currently owned by hedge funds and other institutional investors.

Bionano Genomics Company Profile

Bionano Genomics, Inc provides genome analysis software that enables genomics labs to analyze and interpret data across a range of platforms to generate informative data visualizations for streamlined and simple reporting of causal variants. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel arrays for DNA linearization; and Bionano Prep Kits and DNA labeling kits, which provide the reagents and protocols for extracting and labeling ultra-high molecular weight DNA.